These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26279147)

  • 41. The risk factors for oxaliplatin-induced peripheral sensory neuropathy and thrombocytopenia in advanced gastric cancer.
    Yamaguchi K; Kusaba H; Makiyama A; Mitsugi K; Uchino K; Tamura S; Shibata Y; Esaki T; Ito M; Takayoshi K; Tsuchihashi K; Arita S; Ariyama H; Akashi K; Baba E
    Cancer Chemother Pharmacol; 2018 Oct; 82(4):625-633. PubMed ID: 30043209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Combination Therapy of Pregabalin with Tramadol for Treatment of Peripheral Neuropathy in Patients with Gynecological Cancer Receiving Taxane Containing Chemotherapy].
    Nishikawa T; Hasegawa K; Shintani D; Yano Y; Sato S; Yabuno A; Kurosaki A; Yoshida H; Fujiwara K
    Gan To Kagaku Ryoho; 2017 Mar; 44(3):227-231. PubMed ID: 28292992
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Taxane-induced arthralgia and myalgia: A literature review.
    Chiu N; Chiu L; Chow R; Lam H; Verma S; Pasetka M; Chow E; DeAngelis C
    J Oncol Pharm Pract; 2017 Jan; 23(1):56-67. PubMed ID: 26811404
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Taxane-based regimens as a risk factor for chemotherapy-induced amenorrhea.
    Najafi S; Djavid GE; Mehrdad N; Rajaii E; Alavi N; Olfatbakhsh A; Najafi M; Bahrami A; Heidari K
    Menopause; 2011 Feb; 18(2):208-12. PubMed ID: 21037487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry.
    Oguejiofor OC; Odenigbo CU; Oguejiofor CB
    Niger J Clin Pract; 2010 Sep; 13(3):240-7. PubMed ID: 20857777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peripheral neuropathy in patients with gynecologic cancer receiving chemotherapy: patient reports and provider assessments.
    Kiser DW; Greer TB; Wilmoth MC; Dmochowski J; Naumann RW
    Oncol Nurs Forum; 2010 Nov; 37(6):758-64. PubMed ID: 21059587
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term peripheral neuropathy symptoms in breast cancer survivors.
    Mustafa Ali M; Moeller M; Rybicki L; Moore HCF
    Breast Cancer Res Treat; 2017 Nov; 166(2):519-526. PubMed ID: 28791499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measuring the side effects of taxane therapy in oncology: the functional assesment of cancer therapy-taxane (FACT-taxane).
    Cella D; Peterman A; Hudgens S; Webster K; Socinski MA
    Cancer; 2003 Aug; 98(4):822-31. PubMed ID: 12910528
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and efficacy of first-line bevacizumab combined with taxane therapy in Chinese patients with HER2-negative locally recurrent or metastatic breast cancer: findings from the ATHENA study.
    Xu BH; Jiang ZF; Shen ZZ; Guan ZZ; Chen ZD; Cheng Y; Zheng H; Jiang J; Wang XJ; Tong ZS; Qin SK; Luo Y; Yao M; Wang LW; He J
    Chin Med J (Engl); 2012 Mar; 125(5):764-9. PubMed ID: 22490570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study.
    Thuss-Patience PC; Shah MA; Ohtsu A; Van Cutsem E; Ajani JA; Castro H; Mansoor W; Chung HC; Bodoky G; Shitara K; Phillips GDL; van der Horst T; Harle-Yge ML; Althaus BL; Kang YK
    Lancet Oncol; 2017 May; 18(5):640-653. PubMed ID: 28343975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Taxane-induced peripheral neuropathy and quality of life in breast cancer patients.
    Salehifar E; Janbabaei G; Alipour A; Tabrizi N; Avan R
    J Oncol Pharm Pract; 2020 Sep; 26(6):1421-1428. PubMed ID: 31937190
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cervical non-squamous carcinoma: an effective combination chemotherapy of taxane, anthracycline and platinum for advanced or recurrent cases.
    Kimura T; Miyatake T; Ueda Y; Ohta Y; Enomoto T; Kimura T; Kamiura S
    Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):200-4. PubMed ID: 22770633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma.
    Sonpavde G; Pond GR; Choueiri TK; Mullane S; Niegisch G; Albers P; Necchi A; Di Lorenzo G; Buonerba C; Rozzi A; Matsumoto K; Lee JL; Kitamura H; Kume H; Bellmunt J
    Eur Urol; 2016 Apr; 69(4):634-641. PubMed ID: 26264159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Taxane-induced neurotoxicity: Pathophysiology and therapeutic perspectives.
    da Costa R; Passos GF; Quintão NLM; Fernandes ES; Maia JRLCB; Campos MM; Calixto JB
    Br J Pharmacol; 2020 Jul; 177(14):3127-3146. PubMed ID: 32352155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pain descriptors of taxane acute pain syndrome (TAPS) in breast cancer patients-a prospective clinical study.
    Asthana R; Zhang L; Wan BA; Gallo-Hershberg D; Giotis A; Pasetka M; van Draanen J; Goodall S; Diaz PL; Drost L; Chow E; De Angelis C
    Support Care Cancer; 2020 Feb; 28(2):589-598. PubMed ID: 31098795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigation of a correlation between taxane-based chemotherapy and the ultrasonic time-of-flight of human fingernails.
    Vacarescu RA; Slak B; Maeva A; Hamm C; Lewoc N; Daabous AT; Strumban E; Maev RG
    Skin Res Technol; 2018 Feb; 24(1):20-25. PubMed ID: 28585341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer.
    Nurgalieva Z; Xia R; Liu CC; Burau K; Hardy D; Du XL
    Am J Ther; 2010; 17(2):148-58. PubMed ID: 19417586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carboplatin reinduction after taxane in patients with platinum-refractory epithelial ovarian cancer.
    Kavanagh J; Tresukosol D; Edwards C; Freedman R; Gonzalez de Leon C; Fishman A; Mante R; Hord M; Kudelka A
    J Clin Oncol; 1995 Jul; 13(7):1584-8. PubMed ID: 7602347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis.
    Fontes F; Pereira S; Castro-Lopes JM; Lunet N
    Breast; 2016 Oct; 29():31-8. PubMed ID: 27394676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of salt-water bath in the management of treatment-related peripheral neuropathy in cancer patients receiving taxane and platinum-based treatment.
    Emine KE; Gulbeyaz C
    Explore (NY); 2022; 18(3):347-356. PubMed ID: 34340926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.